Immuno-Oncology

The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.

ASCO 2024: Latest Data in Melanoma

Gain expert insights to the phase 3 NADINA trial and learn more about unmet needs in melanoma management with this Post Conference Perspectives.

Gain expert insights to the phase 3 NADINA trial and learn more about unmet needs in melanoma management with this Post Conference Perspectives.

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo